Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/a-mastery-approach-to-complex-esophageal-diseases-non-operative-LDvylWpBFo
References (65)
-
P. Siersema, L. Wijkerslooth (2009)
Dilation of refractory benign esophageal strictures.Gastrointestinal endoscopy, 70 5
-
I. Gralnek, G. Dulai, M. Fennerty, B. Spiegel (2006)
Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 4 12
-
Nima Arezoomandi, Peyman Adibi (1997)
Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis.Gastroenterology, 112 6
-
W. Fackler, T. Ours, M. Vaezi, J. Richter (2002)
Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough.Gastroenterology, 122 3
-
Kirsten Sigterman, B. Pinxteren, P. Bonis, J. Lau, M. Numans (2013)
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.The Cochrane database of systematic reviews, 4
-
Rui-hua Wang (2015)
From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.World journal of gastroenterology, 21 17
-
S. Hanna, A. Rastogi, A. Weston, F. Totta, Robert Schmitz, S. Mathur, D. Mcgregor, R. Cherian, Prateek Sharma (2000)
Detection of Barrett's Esophagus After Endoscopic Healing of Erosive EsophagitisThe American Journal of Gastroenterology, 101
-
J. Kirchheiner, S. Glatt, U. Fuhr, U. Klotz, I. Meineke, T. Seufferlein, J. Brockmöller (2008)
Relative potency of proton-pump inhibitors—comparison of effects on intragastric pHEuropean Journal of Clinical Pharmacology, 65
-
F. Baldi (2015)
PPI-Refractory GERD: an Intriguing, Probably Overestimated, PhenomenonCurrent Gastroenterology Reports, 17
-
The role of endoscopy in the management of GERD -
G. Schneider, M. Vaezi, D. Francis (2016)
Reflux and Voice Disorders: Have We Established Causality?Current Otorhinolaryngology Reports, 4
-
L. Gerson, R. Fass (2009)
A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 7 4
-
N. Vakil, S. Zanten, P. Kahrilas, J. Dent, Roger Jones (2006)
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based ConsensusThe American Journal of Gastroenterology, 101
-
P. Katz, L. Gerson, M. Vela (2013)
Guidelines for the Diagnosis and Management of Gastroesophageal Reflux DiseaseThe American Journal of Gastroenterology, 108
-
A. Ruigh, Sabine Roman, Joan Chen, Joan Chen, J. Pandolfino, P. Kahrilas (2014)
Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post‐prandial oesophageal acid exposure in GERD patients: a double‐blind crossover studyAlimentary Pharmacology & Therapeutics, 40
-
T. Herregods, F. Hoeij, J. Oors, A. Bredenoord, A. Smout (2016)
Effect of Running on Gastroesophageal Reflux and Reflux MechanismsThe American Journal of Gastroenterology, 111
-
F. Ateş, E. Yuksel, Tina Higginbotham, J. Slaughter, J. Mabary, R. Kavitt, C. Garrett, D. Francis, M. Vaezi (2015)
Mucosal impedance discriminates GERD from non-GERD conditions.Gastroenterology, 148 2
-
O. Nebel, D. Castell (1972)
Lower esophageal sphincter pressure changes after food ingestion.Gastroenterology, 63 5
-
R. Yadlapati, P. Kahrilas (2017)
When is proton pump inhibitor use appropriate?BMC Medicine, 15
-
D. Francis, J. Slaughter, F. Ateş, Tina Higginbotham, Kristin Stevens, C. Garrett, M. Vaezi (2016)
Airway Hypersensitivity, Reflux, and Phonation Contribute to Chronic Cough.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 14 3
-
H. Coleman, Shaohua Xie, J. Lagergren (2017)
The Epidemiology of Esophageal Adenocarcinoma.Gastroenterology, 154 2
-
U. Diener, M. Patti, D. Molena, P. Fisichella, L. Way (2001)
Esophageal dysmotility and gastroesophageal reflux diseaseJournal of Gastrointestinal Surgery, 5
-
C. Scarpignato, L. Gatta, A. Zullo, C. Blandizzi, Carmelo Bal, C. Scarpignato, C. Blandizzi, L. Gatta, A. Zullo, A. Kohn, G. Leandro, A. Balzano, A. Chiriatti, Walter Marocco (2016)
Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppressionBMC Medicine, 14
-
S. Roman, C. Gyawali, E. Savarino, R. Yadlapati, F. Zerbib, J. Wu, M. Vela, R. Tutuian, R. Tatum, D. Sifrim, J. Keller, M. Fox, J. Pandolfino, A. Bredenoord, F. Azpiroz, A. Babaei, S. Bhatia, G. Boeckxstaens, S. Bor, D. Carlson, D. Castell, M. Cicala, J. Clarke, N. Bortoli, V. Drug, M. Frazzoni, R. Holloway, P. Kahrilas, A. Kandulski, P. Katz, D. Katzka, R. Mittal, F. Mion, L. Novais, Amit Patel, R. Penagini, M. Ribolsi, J. Richter, R. Salvador, V. Savarino, J. Serra, F. Schnoll-Sussman, A. Smout, E. Soffer, R. Sweis, J. Tack, S. Tolone, M. Vaezi, P. Woodland, Yinglian Xiao (2017)
Ambulatory reflux monitoring for diagnosis of gastro‐esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus groupNeurogastroenterology & Motility, 29
-
E. Savarino, I. Martinucci, M. Furnari, C. Romana, G. Pellegatta, A. Moscatelli, G. Bodini, E. Marabotto, V. Savarino, N. Bortoli, C. Blandizzi (2016)
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerationsExpert Opinion on Drug Metabolism & Toxicology, 12
-
P. Kahrilas, N. Shaheen, M. Vaezi, S. Hiltz, Edgar Black, I. Modlin, Steve Johnson, John Allen, J. Brill (2008)
American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease.Gastroenterology, 135 4
-
R. Madanick (2014)
Extraesophageal presentations of GERD: where is the science?Gastroenterology clinics of North America, 43 1
-
Sabine Roman, Richard Holloway, Jutta Keller, F. Herbella, Frank Zerbib, Yinglian Xiao, L. Bernard, A. Bredenoord, S. Varannes, M. Chen, Mark Fox, P. Kahrilas, R. Mittal, R. Penagini, E. Savarino, D. Sifrim, J. Wu, E. Decullier, J. Pandolfino, F. Mion (2017)
Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high‐resolution manometryNeurogastroenterology & Motility, 29
-
Y. Chowers, T. Atarot, V. Pratha, R. Fass (2012)
The effect of once daily omeprazole and succinic acid (VECAM) vs once daily omeprazole on 24‐h intragastric pHNeurogastroenterology & Motility, 24
-
M. Derakhshan, E. Robertson, J. Fletcher, Gareth Jones, Y. Lee, A. Wirz, K. McColl (2011)
Mechanism of association between BMI and dysfunction of the gastro-oesophageal barrier in patients with normal endoscopyGut, 61
-
M. Ward, C. Dunst, Ezra Teitelbaum, V. Halpin, K. Reavis, L. Swanström, S. DeMeester (2018)
Impedance-pH monitoring on medications does not reliably confirm the presence of gastroesophageal reflux disease in patients referred for antireflux surgerySurgical Endoscopy, 32
-
K. DeVault, D. Castell (1999)
Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux DiseaseThe American Journal of Gastroenterology, 100
-
Ming-Shiang Wu, S. Tan, T. Xiong (2013)
Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 38
-
J. Richter (1996)
Typical and atypical presentations of gastroesophageal reflux disease. The role of esophageal testing in diagnosis and management.Gastroenterology clinics of North America, 25 1
-
J. Richter, J. Rubenstein (2017)
Presentation and Epidemiology of Gastroesophageal Reflux Disease.Gastroenterology, 154 2
-
Y. Komazawa, K. Adachi, T. Mihara, M. Ono, A. Kawamura, Hirofumi Fujishiro, Y. Kinoshita (2003)
Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infectionJournal of Gastroenterology and Hepatology, 18
-
I. Mainie, R. Tutuian, D. Castell (2008)
Addition of a H2 Receptor Antagonist to PPI Improves Acid Control and Decreases Nocturnal Acid BreakthroughJournal of Clinical Gastroenterology, 42
-
U. Siddiqui, Subhas Banerjee, B. Barth, S. Chauhan, K. Gottlieb, V. Konda, J. Maple, Faris Murad, P. Pfau, D. Pleskow, Jeffrey Tokar, Amy Wang, Sarah Rodriguez (2013)
Tools for endoscopic stricture dilation.Gastrointestinal endoscopy, 78 3
-
Zongli Zheng, K. Margolis, Simin Liu, L. Tinker, W. Ye (2008)
Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux.Gastroenterology, 135 1
-
V. Muthusamy, J. Lightdale, Ruben Acosta, V. Chandrasekhara, K. Chathadi, M. Eloubeidi, R. Fanelli, Lisa Fonkalsrud, A. Faulx, M. Khashab, J. Saltzman, A. Shaukat, Amy Wang, B. Cash, J. DeWitt (2015)
The role of endoscopy in the management of GERD.Gastrointestinal endoscopy, 81 6
-
J. Hatlebakk, P. Katz, L. Camacho-Lobato, D. Castell (2000)
Proton pump inhibitors: better acid suppression when taken before a meal than without a mealAlimentary Pharmacology & Therapeutics, 14
-
J. Shin, G. Sachs (2008)
Pharmacology of proton pump inhibitorsCurrent Gastroenterology Reports, 10
-
M. Wolfe, George Sachs (2000)
Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome.Gastroenterology, 118 2 Suppl 1
-
E. Ness-Jensen, K. Hveem, H. El‐Serag, J. Lagergren (2016)
Lifestyle Intervention in Gastroesophageal Reflux Disease.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 14 2
-
M. Numans, J. Lau, N. Wit, P. Bonis (2004)
Short-Term Treatment with Proton-Pump Inhibitors as a Test for Gastroesophageal Reflux DiseaseAnnals of Internal Medicine, 140
-
H. Yamashita, Atsushi Kanamori, Chise Kano, Hiroki Hashimura, Kei Matsumoto, M. Tsujimae, Tetsuya Yoshizaki, Kenji Momose, D. Obata, T. Eguchi, M. Fujita, Akihiko Okada (2017)
The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump InhibitorsDigestion, 96
-
John Moore, M. Vaezi (2010)
Extraesophageal manifestations of gastroesophageal reflux disease: real or imagined?Current Opinion in Gastroenterology, 26
-
R. Fass, A. Gąsiorowska (2008)
Refractory GERD: What is it?Current Gastroenterology Reports, 10
-
P. Kahrilas (1996)
Gastroesophageal reflux disease.JAMA, 276 12
-
C. Barham, D. Gotley, A. Mills, D. Alderson (1995)
Precipitating causes of acid reflux episodes in ambulant patients with gastro-oesophageal reflux disease.Gut, 36
-
N. Shaheen, D. Weinberg, Thomas Denberg, R. Chou, A. Qaseem, P. Shekelle (2012)
Upper Endoscopy for Gastroesophageal Reflux Disease: Best Practice Advice From the Clinical Guidelines Committee of the American College of PhysiciansAnnals of Internal Medicine, 157
-
R. Lee, M. Vakily, D. Mulford, J. Wu, S. Atkinson (2009)
Clinical trial: the effect and timing of food on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR, a novel Dual Delayed Release formulation of a proton pump inhibitor – evidence for dosing flexibilityAlimentary Pharmacology & Therapeutics, 29
-
T. Ours, W. Fackler, J. Richter, M. Vaezi (2003)
Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure.The American Journal of Gastroenterology, 98
-
D. Leiman, B. Riff, S. Morgan, D. Metz, G. Falk, B. French, C. Umscheid, James Lewis (2017)
Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 30 5
-
S. Xue, P. Katz, Promila Banerjee, R. Tutuian, D. Castell (2001)
Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitorsAlimentary Pharmacology & Therapeutics, 15
-
P. Moayyedi, N. Talley, M. Fennerty, N. Vakil (2006)
Can the clinical history distinguish between organic and functional dyspepsia?JAMA, 295 13
-
C. Hachem, N. Shaheen (2016)
Diagnosis and Management of Functional HeartburnThe American Journal of Gastroenterology, 111
-
I. Hirano, Qing Zhang, J. Pandolfino, P. Kahrilas (2005)
Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 3 11
-
D. Freedberg, Lawrence Kim, Yu-Xiao Yang (2017)
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.Gastroenterology, 152 4
-
L. Wallin, T. Madsen (1979)
12-Hour simultaneous registration of acid reflex and peristaltic activity in the oesophagus. A study in normal subjects.Scandinavian journal of gastroenterology, 14 5
-
V. Phupong, T. Hanprasertpong (2015)
Interventions for heartburn in pregnancy.The Cochrane database of systematic reviews, 9
-
M. Vaezi, Y. Choksi (2017)
Mucosal Impedance: A New Way To Diagnose Reflux Disease and How It Could Change Your PracticeThe American Journal of Gastroenterology, 112
-
G. Vitale, W. Cheadle, Bijesh Patel, S. Sadek, M. Michel, A. Cuschieri (1987)
The effect of alcohol on nocturnal gastroesophageal reflux.JAMA, 258 15
-
N. Shaheen, G. Falk, P. Iyer, L. Gerson (2016)
ACG Clinical Guideline: Diagnosis and Management of Barrett’s EsophagusThe American Journal of Gastroenterology, 111
-
N. Gunaratnam, T. Jessup, J. Inadomi, D. Lascewski (2006)
Sub‐optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 23
- Publisher
- Springer International Publishing
- Copyright
- © Springer International Publishing AG, part of Springer Nature 2018
- ISBN
- 978-3-319-75794-0
- Pages
- 1 –15
- DOI
- 10.1007/978-3-319-75795-7_1
- Publisher site
- See Chapter on Publisher Site
Abstract
[Gastrointestinal reflux disease (GERD) is the most prevalent gastrointestinal disorder in the United States with considerable morbidity. It is typically characterized by the classic symptoms of heartburn and regurgitation. The management of GERD includes assessment for alarm features which should prompt further investigation. However, in most cases GERD is a presumptive diagnosis that can be treated empirically with proton pump inhibitor (PPI) therapy without extensive diagnostic evaluation. This chapter will review the non-operative management of GERD, including medical therapy as well as the additional diagnostic for patients at risk for complications of GERD.]
Published: Apr 21, 2018
Keywords: Acid reflux; Heartburn; Esophagitis; Barrett’s esophagus; Esophageal stricture; Proton pump inhibitor